Literature DB >> 18712646

Accuracy of uniaxial accelerometer in chronic obstructive pulmonary disease.

Marilyn L Moy1, Eric Garshick, Kirby R Matthess, Robert Lew, John J Reilly.   

Abstract

Wearable sensors have been developed and used in nondisabled adults. Little is known about their accuracy in patients with chronic disease. We tested the ActiHealth accelerometer, which measures step counts, in subjects with chronic obstructive pulmonary disease (COPD). We determined the intra- and interdevice coefficients of variation (CVs). We assessed the accuracy of the device in 15 nondisabled males and 46 subjects with COPD. Accuracy was defined as percent step capture, (device step count divided by manual step count) times 100. Predictors of percent step capture were identified using linear regression methods. The accelerometer has an intradevice CV ranging from 0.008 to 0.025 and an interdevice CV of 0.64. In nondisabled males, median percent step capture was 96% (interquartile range 81%-98%). In subjects with COPD, median percent step capture was 86% (interquartile range 72%-96%). Usual walking speed was the most important predictor of percent step capture (p = 0.004). The ActiHealth accelerometer has acceptable intra- and interdevice CVs. It is highly accurate in nondisabled subjects. The accuracy declines in subjects with COPD based on walking speed. Prior to using the ActiHealth accelerometer, researchers and clinicians should assess walking speed and percent step capture in each subject.

Entities:  

Mesh:

Year:  2008        PMID: 18712646      PMCID: PMC2538610          DOI: 10.1682/jrrd.2007.09.0147

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  23 in total

1.  Ambulatory estimates of maximal aerobic power from foot -ground contact times and heart rates in running humans.

Authors:  P G Weyand; M Kelly; T Blackadar; J C Darley; S R Oliver; N E Ohlenbusch; S W Joffe; R W Hoyt
Journal:  J Appl Physiol (1985)       Date:  2001-07

2.  Monitoring daily activity during pulmonary rehabilitation using a triaxial accelerometer.

Authors:  Bonnie G Steele; Basia Belza; Jim Hunziker; Lyn Holt; Marcia Legro; Jeff Coppersmith; David Buchner; Sambasiva Lakshminaryan
Journal:  J Cardiopulm Rehabil       Date:  2003 Mar-Apr       Impact factor: 2.081

3.  Ambulatory monitoring of cumulative free-living activity.

Authors:  Marilyn L Moy; Steven J Mentzer; John J Reilly
Journal:  IEEE Eng Med Biol Mag       Date:  2003 May-Jun

4.  Technical reliability assessment of three accelerometer models in a mechanical setup.

Authors:  Dale W Esliger; Mark S Tremblay
Journal:  Med Sci Sports Exerc       Date:  2006-12       Impact factor: 5.411

5.  Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.

Authors:  Judith Garcia-Aymerich; Peter Lange; Marta Benet; Peter Schnohr; Josep M Antó
Journal:  Am J Respir Crit Care Med       Date:  2006-12-07       Impact factor: 21.405

6.  Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

Authors:  J Garcia-Aymerich; P Lange; M Benet; P Schnohr; J M Antó
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

7.  Physical activity-related energy expenditure with the RT3 and TriTrac accelerometers in overweight adults.

Authors:  David Jacobi; Anne-Elisabeth Perrin; Natacha Grosman; Marie-France Doré; Sylvie Normand; Jean-Michel Oppert; Chantal Simon
Journal:  Obesity (Silver Spring)       Date:  2007-04       Impact factor: 5.002

8.  Field validation of the MTI Actigraph and BodyMedia armband monitor using the IDEEA monitor.

Authors:  Gregory J Welk; James J McClain; Joey C Eisenmann; Eric E Wickel
Journal:  Obesity (Silver Spring)       Date:  2007-04       Impact factor: 5.002

9.  Quantitating physical activity in COPD using a triaxial accelerometer.

Authors:  B G Steele; L Holt; B Belza; S Ferris; S Lakshminaryan; D M Buchner
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

Review 10.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

View more
  6 in total

1.  Daily step counts in a US cohort with COPD.

Authors:  Marilyn L Moy; Valery A Danilack; Nicole A Weston; Eric Garshick
Journal:  Respir Med       Date:  2012-04-20       Impact factor: 3.415

2.  Use of pedometer and Internet-mediated walking program in patients with chronic obstructive pulmonary disease.

Authors:  Marilyn L Moy; Adrienne W Janney; Huong Q Nguyen; Kirby R Matthess; Miriam Cohen; Eric Garshick; Caroline R Richardson
Journal:  J Rehabil Res Dev       Date:  2010

3.  Free-living physical activity in COPD: assessment with accelerometer and activity checklist.

Authors:  Marilyn L Moy; Kirby Matthess; Kelly Stolzmann; John Reilly; Eric Garshick
Journal:  J Rehabil Res Dev       Date:  2009

4.  An internet-based virtual coach to promote physical activity adherence in overweight adults: randomized controlled trial.

Authors:  Alice Watson; Timothy Bickmore; Abby Cange; Ambar Kulshreshtha; Joseph Kvedar
Journal:  J Med Internet Res       Date:  2012-01-26       Impact factor: 5.428

5.  Effect of body weight support on predicted locomotive physical activity.

Authors:  Yoshiya Fujika; Hironobu Hamada; Kiyokazu Sekikawa; Teruki Kajiwara; Hikaru Yamamoto; Norimichi Kamikawa
Journal:  J Phys Ther Sci       Date:  2018-06-12

6.  Counting Steps in Activities of Daily Living in People With a Chronic Disease Using Nine Commercially Available Fitness Trackers: Cross-Sectional Validity Study.

Authors:  Darcy Ummels; Emmylou Beekman; Kyra Theunissen; Susy Braun; Anna J Beurskens
Journal:  JMIR Mhealth Uhealth       Date:  2018-04-02       Impact factor: 4.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.